Lobbying registrant · LD-2 disclosures
Lupin Pharmaceuticals Inc
Maryland
34 filings · 1 client · 1 lobbyist registered · 2018–2026 · latest filed Jul 24, 2026
Fees billed to clients
$75K
every LD-2 fee on file
Its own lobbying spend
$4M
filed on its own behalf
Clients represented
1
1 lobbyist registered
Note · At least one filing discloses a foreign entity with an interest in a client this registrant represents. Those disclosures are listed below.
Revenue over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who they lobby for
Every client this registrant has billed a fee to represent, by fees reported.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Medicare/Medicaid
MMM · 1 client
34 filings
$4M on those filings
Pharmacy
PHA · 1 client
34 filings
$4M on those filings
Health Issues
HCR · 1 client
Who does the lobbying
Every lobbyist named on this registrant's filings.
- SHAWN BROWN esqCovered position: VP Government Affairs37 filings1 client · through 2026
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. A covered official position is the LD-2 field a lobbyist uses to report having held one; the text is reproduced exactly as filed.
Foreign interests disclosed
Every foreign entity named on this registrant's filings.
Lupin Ltd.
India
1 filing
through 2021
Lupin Limited
India
1 filing
through 2018
What this discloses · An LD-2 reports foreign entities that hold an interest in, or contribute to, the client — so these are foreign interests behind the organizations this registrant files for, not owners of the registrant itself. Disclosure is a reporting requirement, not an allegation.
The filings
The 20 most recent of 34 filings. Every figure above is built from these records.
This record groups every filed spelling of the registrant's name into one entity, so punctuation variants of the same firm read as one. The grouping is the registrant's normalized name — firms that file under genuinely different names appear separately. Handle: lupin-pharmaceuticals-inc.